Consistently, the authors showed that a decreased expression of hsa-let7a-2-3p and hsa-miR-135a-5p made AML cells more sensitive to FAK inhibitors VS-4718 (1.5 μM) and defactinib (1 μM) (35). Here, PTK2 is linked to acute myeloid leukemia.